Why Is the ResMed Share Price Taking a Thumping on Thursday?

The Motley FoolSep 19 10:48

ResMed Stock Is S&P 500's Worst Performer. GLP-1 Drugs Are a Risk. -- Barrons.com

Barron'sSep 18 23:24

ResMed Cut to Underperform From Peer Perform by Wolfe Research

Dow JonesSep 18 18:01 · Ratings

ResMed Lauds Apple's Sleep Apnoea Detection Feature

Investing.com Sep 13 09:30

Analysts Offer Insights on Healthcare Companies: Y-Mabs Therapeutics (YMAB), Resmed Inc CHESS Depositary Interests on a Ratio of 10 CDIs per Ord.sh (AU:RMD) and Bayer (GB:0P6S)

TipRanksSep 11 17:02 · Ratings

Express News | Resmed Inc - 16% Reduction in Death Risk for Copd Patients Using Home Niv Support

BreakingsSep 10 20:02